WO2001013887A3 - Phospholipidgel - Google Patents

Phospholipidgel Download PDF

Info

Publication number
WO2001013887A3
WO2001013887A3 PCT/EP2000/007993 EP0007993W WO0113887A3 WO 2001013887 A3 WO2001013887 A3 WO 2001013887A3 EP 0007993 W EP0007993 W EP 0007993W WO 0113887 A3 WO0113887 A3 WO 0113887A3
Authority
WO
WIPO (PCT)
Prior art keywords
gel
phospholipin
pentahydric
tetrahydric
liquefying
Prior art date
Application number
PCT/EP2000/007993
Other languages
English (en)
French (fr)
Other versions
WO2001013887A2 (de
Inventor
Bernd Ibscher
Ruland Fridrich
Original Assignee
Merckle Gmbh
Bernd Ibscher
Ruland Fridrich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh, Bernd Ibscher, Ruland Fridrich filed Critical Merckle Gmbh
Priority to HU0203097A priority Critical patent/HUP0203097A3/hu
Priority to EP00960468A priority patent/EP1206245A2/de
Priority to AU72767/00A priority patent/AU776766B2/en
Priority to JP2001518026A priority patent/JP2003507408A/ja
Priority to PL00353215A priority patent/PL353215A1/xx
Priority to CA002381571A priority patent/CA2381571A1/en
Priority to SK244-2002A priority patent/SK2442002A3/sk
Publication of WO2001013887A2 publication Critical patent/WO2001013887A2/de
Publication of WO2001013887A3 publication Critical patent/WO2001013887A3/de
Priority to NO20020768A priority patent/NO20020768D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052—Preparation of gels
    • B01J13/0065—Preparation of gels containing an organic phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Es wird ein Phospholipidgel offenbart, das durch Zusatz eines 4-, 5- oder 6-wertigen Alkohols oder Zuckers gegen Verflüssigen stabilisiert ist. Das Gel eignet sich zur Herstellung von kosmetischen und pharmazeutischen Formulierungen.
PCT/EP2000/007993 1999-08-25 2000-08-16 Phospholipidgel WO2001013887A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
HU0203097A HUP0203097A3 (en) 1999-08-25 2000-08-16 Phospholipid gel
EP00960468A EP1206245A2 (de) 1999-08-25 2000-08-16 Phospholipidgel
AU72767/00A AU776766B2 (en) 1999-08-25 2000-08-16 Phospholipin gel
JP2001518026A JP2003507408A (ja) 1999-08-25 2000-08-16 リン脂質ゲル
PL00353215A PL353215A1 (en) 1999-08-25 2000-08-16 Phospholipin gel
CA002381571A CA2381571A1 (en) 1999-08-25 2000-08-16 Phospholipid gel
SK244-2002A SK2442002A3 (en) 1999-08-25 2000-08-16 Phospholipid gel
NO20020768A NO20020768D0 (no) 1999-08-25 2002-02-15 Fosfolipidgel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19940227A DE19940227A1 (de) 1999-08-25 1999-08-25 Phospholipidgel
DE19940227.2 1999-08-25

Publications (2)

Publication Number Publication Date
WO2001013887A2 WO2001013887A2 (de) 2001-03-01
WO2001013887A3 true WO2001013887A3 (de) 2001-09-20

Family

ID=7919498

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/007993 WO2001013887A2 (de) 1999-08-25 2000-08-16 Phospholipidgel

Country Status (13)

Country Link
EP (1) EP1206245A2 (de)
JP (1) JP2003507408A (de)
AU (1) AU776766B2 (de)
CA (1) CA2381571A1 (de)
CZ (1) CZ2002561A3 (de)
DE (1) DE19940227A1 (de)
HU (1) HUP0203097A3 (de)
NO (1) NO20020768D0 (de)
PL (1) PL353215A1 (de)
RU (1) RU2261088C2 (de)
SK (1) SK2442002A3 (de)
WO (1) WO2001013887A2 (de)
ZA (1) ZA200201506B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011252887B2 (en) * 2010-05-14 2016-05-12 Archer Daniels Midland Company Food compositions comprising organogels

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062316A1 (de) * 2001-02-08 2002-08-15 Vectron Therapeutics Ag Invasomen zur therapie von erkrankungen, ihre herstellung und verwendung
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
DE10255285A1 (de) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Selbst formende Phospholipid-Gele
DE10255195A1 (de) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
ES2301886T3 (es) * 2002-12-20 2008-07-01 Idexx Laboratories, Inc. Formulacion analgesica liposomal que comprende diclofenac y su uso para tratamiento de caballos.
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
FI20065222L (fi) * 2006-04-05 2007-10-06 Finnfeeds Finland Oy Inositolin käyttö
ITMI20081862A1 (it) * 2008-10-21 2010-04-22 Funziona Srl Composizione ad uso topico per il trattamento delle adiposita' localizzate e dei relativi inestetismi
EP2355803A4 (de) * 2008-11-14 2012-04-25 Archer Daniels Midland Co Organogel-zusammensetzungen und herstellungsverfahren
EP2210589B1 (de) * 2009-01-22 2015-05-06 Ludwig-Maximilians-Universität München Vesikuläre Phospholipid-Gele mit proteinösen Substanzen
BE1018506A3 (nl) * 2009-02-26 2011-02-01 Bogaert Gina Van Samenstelling van een hydrocortisone, zijn derivaten, metabolieten, prodrugs of mengsels daarvan houdende liposomale gel en het gebruik ervan.
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
LT3600435T (lt) 2017-03-23 2024-04-25 Lipid Systems Sp. Z.O.O. Hidrofilinių junginių aukšto efektyvumo įkapsuliavimas vienasluoksnėse liposomose

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158441A2 (de) * 1984-03-08 1985-10-16 Phares Pharmaceutical Holland B.V. Liposombildende Zusammensetzung
JPS649931A (en) * 1987-07-02 1989-01-13 Daiichi Seiyaku Co Stabilized liposome preparation
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
DE4021082A1 (de) * 1990-07-03 1992-01-23 Hans Dr Lautenschlaeger Hautbehandlungsmittel mit hohen lipidgehalten unter verwendung eines bilayer enthaltenden systems, salzen organischer saeuren, alkohol und stabilisator
DE19520659A1 (de) * 1995-06-09 1996-12-12 Mika Pharma Ges Fuer Die Entwi Pharmazeutische Zubereitung zur Therapie und/oder Prophylaxe von durch Viren bedingten Erkrankungen der Haut und/oder der Schleimhaut

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
DE4003783C2 (de) * 1990-02-08 1999-03-25 Nattermann A & Cie Phospholipidhaltiges Gel, Verfahren zu dessen Herstellung und Verwendung
DE19719604A1 (de) * 1997-05-09 1998-07-16 Henkel Kgaa Färbemittel für Keratinfasern

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158441A2 (de) * 1984-03-08 1985-10-16 Phares Pharmaceutical Holland B.V. Liposombildende Zusammensetzung
JPS649931A (en) * 1987-07-02 1989-01-13 Daiichi Seiyaku Co Stabilized liposome preparation
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
DE4021082A1 (de) * 1990-07-03 1992-01-23 Hans Dr Lautenschlaeger Hautbehandlungsmittel mit hohen lipidgehalten unter verwendung eines bilayer enthaltenden systems, salzen organischer saeuren, alkohol und stabilisator
DE19520659A1 (de) * 1995-06-09 1996-12-12 Mika Pharma Ges Fuer Die Entwi Pharmazeutische Zubereitung zur Therapie und/oder Prophylaxe von durch Viren bedingten Erkrankungen der Haut und/oder der Schleimhaut

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198908, Derwent World Patents Index; Class A96, AN 1989-057692, XP002160641 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011252887B2 (en) * 2010-05-14 2016-05-12 Archer Daniels Midland Company Food compositions comprising organogels

Also Published As

Publication number Publication date
RU2261088C2 (ru) 2005-09-27
WO2001013887A2 (de) 2001-03-01
AU776766B2 (en) 2004-09-23
NO20020768L (no) 2002-02-15
AU7276700A (en) 2001-03-19
EP1206245A2 (de) 2002-05-22
SK2442002A3 (en) 2002-08-06
JP2003507408A (ja) 2003-02-25
PL353215A1 (en) 2003-11-03
HUP0203097A3 (en) 2006-11-28
DE19940227A1 (de) 2001-03-08
CZ2002561A3 (cs) 2002-07-17
NO20020768D0 (no) 2002-02-15
ZA200201506B (en) 2003-05-28
CA2381571A1 (en) 2001-03-01
HUP0203097A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
WO2001013887A3 (de) Phospholipidgel
HU230005B1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU2002362712A1 (en) Galenic microparticulate oral formulation
EP0960621A3 (de) Pharmazeutische Zusammensetzungen enthaltend sildenafil
CA2469369A1 (en) Compositions containing both sedative and non-sedative antihistamines
AU2001265007A1 (en) Open-back hat
AU2001296029A1 (en) Pharmaceutical preparation of percutaneous absorption type
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
AU2002363436A1 (en) Polyvalent immunogen of hiv
AU2001243497A1 (en) Reduced-risk agricultural transactions
WO2003053394A3 (de) Verwendungen von apfelkernextrakten in kosmetischen oder pharmazeutischen zusammensetzungen
EP2017269A3 (de) Krystalline Form II von Ritonavir enthaltende pharmazeutische Zusammensetzung und ihre Herstellung
AU1653701A (en) Dynamic spectral shaping for fiber-optic application
AU2001289729A1 (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
EP1228747A3 (de) Kosmetische Formulierung
WO2002060435A8 (fr) Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer
WO2002060906A3 (en) Crystal modification of olanzapine
AU4835496A (en) Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
AU2003292297A1 (en) Novel dermatological and/or cosmetologic hydrating and anti-irritation compositions
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
CA2369825A1 (en) Microstructured components
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
WO2002038110A3 (fr) Utilisation de carbohydrate pour ameliorer la fonction barriere de la peau

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CZ HU JP NO PL RU SK US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA CZ HU JP NO PL RU SK US ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000960468

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2381571

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PV2002-561

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 2442002

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 72767/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2002 2002104972

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 10069357

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000960468

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV2002-561

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 72767/00

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2000960468

Country of ref document: EP